demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 (hospitalized or not)
potential COVID-19 treatments
adjuvant therapies
anticoagulant Ayerbe HEP-COVID
anticoagulant, curative dose Gonzalez-Porras Gonzalez-Porras
anticoagulant, pre-admission Tremblay Rossi Russo
anticoagulant, prophylactic dose Trinh Gonzalez-Porras Gonzalez-Porras
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies Esba
colchicine Manenti
non-steroidal anti-inflammatory drugs Abu Esba LC ... Park Gianfransesco Kragholm Lund
Ibuprofen Rinott
corticosteroids Husain Wu
Immunostimulants drugs
levamisole Roostaei
neutralizing antibody
casirivimab/imdevimab (Ronapreve) Wei
Immunosuppressants drugs
anti-interleukin-6
tocilizumab Hong Zhao
statins Zhang
antiandrogenic
5-alpha-reductase inhibitors Lazzeri
antiviral and associated therapy
azithromycin Hsia
chloroquine and derivatives
chloroquine Hsia
hydroxychloroquine Hsia
doxycycline Husain
ivermectin NCT04429711 ...
zinc Abd-Elsalam
Drugs for acid related disorders
proton pump inhibitors (PPI) Luxenburger Ullah ... Lee ...
miscellaneous
nicotin Hopkinson
radiotherapy Hess ...
Oral antidiabetic drugs
DPP-4 inhibitor Rhee
Renin-angiotensin-system-acting agents Bae Reynolds ... Anzola
angiotensin converting enzyme inhibitors (ACEIs) Bravi Christiansen Anzola
angiotensin receptor blockers (ARBs) Rhee Bravi Christiansen Anzola
vaccines Bahl ...

12 studies excluded by filtering options 2

5347 Mehra, 2020 2124excludednot a RCThigh risk of bias
5521 Del Amo, 2020 200excludedrisk of bias not avaialble
7070 PHE variants (Technical briefing 12 22 may 2021), 2021 2202excludednot a RCT
7420 PHE (Stowe), 2021 2133excludednot a RCThigh risk of bias
8149 PHE Technical briefing 16 (11/18 June 2021), 2021 2133excludednot a RCThigh risk of bias
8275 Musser, 2021 2130excludednot a RCTrisk of bias not avaialble
8350 Rosenberg, 2021 2130excludednot a RCTrisk of bias not avaialble
8515 Scobie, 2021 2200excludednot a RCTrisk of bias not avaialble
9170 UKHSA report 33 (23 december 2021), 2021 2200excludednot a RCTrisk of bias not avaialble
9176 UKHSA 31 december 2021, 2021 2200excludednot a RCTrisk of bias not avaialble
9214 Southern California (Lewnard), 2022 2130excludednot a RCTrisk of bias not avaialble
9294 UKHSA (report W4- 27 January), 2022 2120excludednot a RCTrisk of bias not avaialble